PRODUCT INNOVATION. PATIENT IMPACT. Trademark

Trademark Overview


On Wednesday, October 19, 2022, a trademark application was filed for PRODUCT INNOVATION. PATIENT IMPACT. with the United States Patent and Trademark Office. The USPTO has given the PRODUCT INNOVATION. PATIENT IMPACT. trademark a serial number of 97638112. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 7, 2024. This trademark is owned by Concert Pharmaceuticals, Inc.. The PRODUCT INNOVATION. PATIENT IMPACT. trademark is filed in the Pharmaceutical Products category with the following description:

A full line of pharmaceuticals, namely, pharmaceutical preparations for the treatment of alopecia, cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
product innovation. patient impact.

General Information


Serial Number97638112
Word MarkPRODUCT INNOVATION. PATIENT IMPACT.
Filing DateWednesday, October 19, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesA full line of pharmaceuticals, namely, pharmaceutical preparations for the treatment of alopecia, cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSUN PHARMACEUTICAL INDUSTRIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540

Party NameSUN PHARMACEUTICAL INDUSTRIES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540

Party NameConcert Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Wednesday, August 2, 2023NON-FINAL ACTION E-MAILED
Saturday, October 22, 2022NEW APPLICATION ENTERED
Wednesday, November 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 14, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 2, 2023ASSIGNED TO EXAMINER
Wednesday, August 2, 2023NON-FINAL ACTION WRITTEN
Wednesday, August 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 1, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, November 1, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, January 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT